Lifestyle intervention can be effective when treating non-alcoholic fatty liver diseases
(NAFLD) patients. Weight loss decreases cardiovascular and diabetes risk and can also …

Vitamin D (calciferol) is a fat-soluble vitamin that has a significant role in phospho-calcium
metabolism, maintaining normal calcium levels and bone health development. The most …

Non-alcoholic fatty liver disease (NAFLD) is the first cause of chronic liver disease
worldwide; it ranges from simple steatosis to steatohepatitis (NASH) and, potentially …

Non-alcoholic fatty liver disease (NAFLD) is a clinical condition characterized by lipid
infiltration of the liver, highly prevalent in the general population affecting 25% of adults, with …

Background: Cardiovascular disease (CVD) risk factors are associated with low serum 25
hydroxyvitamin D (25 (OH) D) concentrations in observational studies; however, clinical trial …

Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around
10–25% of the general adult population, 15% of children, and even> 50% of individuals who …

Background There is conflicting evidence on the effect of vitamin D on glycemic control.
Therefore, in the current meta-analyses, we aimed to assess the effect of vitamin D …

Das Fortschreiten einer NASH ist assoziiert mit Leberzellstress, konsekutiver Entzündung
und Fibrose, mit potentieller Entwicklung einer Leberzirrhose, portaler Hypertension und der …

Vitamin D has been suggested as a protective compound for diabetes mellitus. Several
mechanisms linking vitamin D to the regulation of the immune response support a role for …

Background & Aims It is important to know the extent of the placebo effect in designing
randomized controlled trials for patients with nonalcoholic steatohepatitis (NASH), to …